• Welcome to VilactoBio Official Website
  • E-commerce Portal
  • Contacts
0 Items
VILACT
  • Home
  • About
    • About VILACTOBIO
    • How it all started
    • Management Team
    • Our Strategy
    • Mission & Vision
    • Use Of Technology
    • IP Patent Rights
    • Locations
  • LACTOACTIVE iTHER®
  • Why VILACTOBIO
    • Bovine Colostrum
    • Scientific Description
  • Science
    • Anti-Inflammatory Mediators
    • Immune System Factors
    • Inflammatory Disorders & Anti-inflammatory Treatments
    • Diseases
      • Blistering Skin Disease
      • Diabetic Ulcers Disease
      • Systemic Lupus Erythematosus (SLE) Disease
      • Psoriasis Disease
  • News & Media
    • Company News
  • Investors
    • Investor Info
    • SEC FILINGS
    • FAQ’s
    • XBRL Filings
  • Buy VILACT®
Select Page

Vilacto Bio Announces Launch of Carmen Electra by Vilact®

by admin | Oct 1, 2018 | Company News

Vilacto Bio Announces Launch of Carmen Electra by Vilact® Press Release | 10/01/2018 COPENHAGEN, Denmark, Oct. 01, 2018 (GLOBE NEWSWIRE) — Vilacto Bio Inc. (OTC QB:VIBI) has launched its new skincare product, Carmen Electra by Vilact, based on the company’s...

Recent Posts

  • Vilacto Bio offering natural alternatives to strong drugs in the Psoriasis and diabetics market
  • Vilacto Bio Canada Patent LACTOACTIVE® Granted
  • Vilacto Bio Secured Patent Applications for LACTOACTIVE®
  • Vilacto Bio Announces Launch of Carmen Electra by Vilact®
  • Vilacto Bio Unveils Development Programs for LACTOACTIVE iTHER®

Categories

  • Company News
  • Uncategorized

Meta

  • Log in
  • Entries RSS
  • Comments RSS
  • WordPress.org

Archives

  • April 2019
  • March 2019
  • November 2018
  • October 2018
  • September 2018
  • July 2018
  • June 2018
  • May 2018
  • January 2018
  • November 2017
  • October 2017
  • August 2017
  • July 2017
  • February 2017
  • January 2017
  • October 2016
  • March 2016

Recent Comments

  • admin on Vilacto Bio Announces Launch of Carmen Electra by Vilact®
  • Mary Ann Anderson on Vilacto Bio Announces Launch of Carmen Electra by Vilact®

About Us

At Vilacto Bio, we work at the intersection of pharmaceutical compounds and nanoparticle drug delivery systems (NDDS). Our corporate headquarters are located in Denmark, where we also maintain research and production facilities, and manage our Vilact skincare business.

Recent Posts

  • Vilacto Bio offering natural alternatives to strong drugs in the Psoriasis and diabetics market April 9, 2019
  • Vilacto Bio Canada Patent LACTOACTIVE® Granted March 26, 2019

Sign Up For Updates

© 2018 VILACT - All Rights Reserved